Back to People & Entities
post-mkt
Organization
2
Total Mentions
2
Documents
8
Connected Entities
Organization referenced in documents
Document Mentions (2)
EFTA00848760.pdf
1 mentionEFTA00848760
ter further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet age-related macular degeneration. AAVL down 20% post-mkt after 112k shrs traded. * AAVL instead will run added preclinical studies to investigate optimal dose and delivery of AVA-101 and AVA-201 vs stand
EFTA01368503.pdf
1 mentionEFTA01368503
ter further analyses of previously reported Phase 2a data of AVA-101 for potential treatment of wet age-related macular degeneration. AAVL down 20% post-mkt after 112k shrs traded. * AAVL instead will run added preclinical studies to investigate optimal dose and delivery of AVA-101 and AVA-201 vs stand
Sponsored
Connected Entities(8)
Bloomberg L.P.
OrganizationAmerican privately held financial, software, data, and media company
2 docs2 co-mentions
AVA-101
OrganizationOrganization referenced in documents
2 docs2 co-mentions
AF
Avalanche Bio Falls
PersonName reference in documents
2 docs2 co-mentions
JC
Jeremy R. Cooke
PersonName reference in documents
2 docs2 co-mentions
Avalanche Biotechnologies, Inc.
OrganizationOrganization referenced in documents
2 docs2 co-mentions
AVA-101 Program
OrganizationOrganization referenced in documents
2 docs2 co-mentions
Controversial Data
OrganizationOrganization referenced in documents
2 docs2 co-mentions
NH BFW
OrganizationOrganization referenced in documents
2 docs2 co-mentions